melatonin has been researched along with Uveal Neoplasms in 3 studies
Uveal Neoplasms: Tumors or cancer of the UVEA.
Excerpt | Relevance | Reference |
---|---|---|
" One hundred patients recently diagnosed with non-metastatic uveal melanoma will be randomized to either treatment with adjuvant melatonin 20 mg (4 tablets of 5 mg) at 10 pm for 5 years, or to standard follow-up (control group)." | 9.69 | Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. ( Hagström, A; Kal Omar, R; Stålhammar, G, 2023) |
"The effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells were studied." | 7.70 | Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. ( Hu, DN; McCormick, SA; Roberts, JE, 1998) |
"Melatonin may also enhance the efficacy of cancer treatments such as immuno- and chemotherapy." | 6.82 | The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. ( Hagström, A; Kal Omar, R; Stålhammar, G; Williams, PA, 2022) |
" One hundred patients recently diagnosed with non-metastatic uveal melanoma will be randomized to either treatment with adjuvant melatonin 20 mg (4 tablets of 5 mg) at 10 pm for 5 years, or to standard follow-up (control group)." | 5.69 | Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. ( Hagström, A; Kal Omar, R; Stålhammar, G, 2023) |
"The effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells were studied." | 3.70 | Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. ( Hu, DN; McCormick, SA; Roberts, JE, 1998) |
"Melatonin may also enhance the efficacy of cancer treatments such as immuno- and chemotherapy." | 2.82 | The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. ( Hagström, A; Kal Omar, R; Stålhammar, G; Williams, PA, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hagström, A | 2 |
Kal Omar, R | 2 |
Williams, PA | 1 |
Stålhammar, G | 2 |
Hu, DN | 1 |
McCormick, SA | 1 |
Roberts, JE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adjuvant Melatonin for Uveal Melanoma: A Randomized Open Phase III Study[NCT05502900] | Phase 3 | 100 participants (Anticipated) | Interventional | 2022-10-02 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for melatonin and Uveal Neoplasms
Article | Year |
---|---|
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.
Topics: Humans; Melanoma; Melatonin; Uveal Neoplasms | 2022 |
1 trial available for melatonin and Uveal Neoplasms
Article | Year |
---|---|
Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study.
Topics: Adult; Clinical Trials, Phase III as Topic; Humans; Melanoma; Melatonin; Randomized Controlled Trial | 2023 |
1 other study available for melatonin and Uveal Neoplasms
Article | Year |
---|---|
Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells.
Topics: Cell Division; Dose-Response Relationship, Drug; Humans; Kynurenine; Melanoma; Melatonin; Serotonin; | 1998 |